SEC Filing: Form 425
Prospectuses and communications, business combinations
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Prospectuses and communications, business combinations
Statement of changes in beneficial ownership of securities – amendment
Current report
Statement of changes in beneficial ownership of securities – amendment
Prospectuses and communications, business combinations
Statement of changes in beneficial ownership of securities – amendment